These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26175400)

  • 1. Prospects in cancer immunotherapy: treating advanced stage disease or preventing tumor recurrence?
    Manjili MH; Payne KK
    Discov Med; 2015 Jun; 19(107):427-31. PubMed ID: 26175400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy of cancer: targeting cancer during active disease or during dormancy?
    Shah SA; Zarei M; Manjili SH; Guruli G; Wang XY; Manjili MH
    Immunotherapy; 2017 Sep; 9(11):943-949. PubMed ID: 29338608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inherent premise of immunotherapy for cancer dormancy.
    Manjili MH
    Cancer Res; 2014 Dec; 74(23):6745-9. PubMed ID: 25411346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Veterinary Oncology Immunotherapies.
    Bergman PJ
    Vet Clin North Am Small Anim Pract; 2018 Mar; 48(2):257-277. PubMed ID: 29224713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular immunotherapy in ovarian cancer: Targeting the stem of recurrence.
    Wefers C; Lambert LJ; Torensma R; Hato SV
    Gynecol Oncol; 2015 May; 137(2):335-42. PubMed ID: 25727651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent developments in therapeutic cancer vaccines.
    Morse MA; Chui S; Hobeika A; Lyerly HK; Clay T
    Nat Clin Pract Oncol; 2005 Feb; 2(2):108-13. PubMed ID: 16264883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravesical chemo-immunotherapy in non muscle invasive bladder cancer.
    Leopardo D; Cecere SC; Di Napoli M; Cavaliere C; Pisano C; Striano S; Marra L; Menna L; Claudio L; Perdonà S; Setola S; Berretta M; Franco R; Tambaro R; Pignata S; Facchini G
    Eur Rev Med Pharmacol Sci; 2013 Aug; 17(16):2145-58. PubMed ID: 23893180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cell immunotherapy in ovarian cancer.
    Stiff PJ; Czerlanis C; Drakes ML
    Expert Rev Anticancer Ther; 2013 Jan; 13(1):43-53. PubMed ID: 23259426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
    Gray A; Raff AB; Chiriva-Internati M; Chen SY; Kast WM
    Immunol Rev; 2008 Apr; 222():316-27. PubMed ID: 18364011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer vaccines: emphasis on pediatric cancers.
    Guinipero T; Finn OJ
    Curr Pharm Des; 2010 Jan; 16(3):292-9. PubMed ID: 20109138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunotherapy of superficial bladder tumors in a hospital department].
    Prekopp G; Rosdy E
    Orv Hetil; 1993 Dec; 134(50):2757-60. PubMed ID: 8265124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine studies demonstrate promise of immunotherapy to treat breast cancer and prevent recurrence.
    Oncology (Williston Park); 2000 Oct; 14(10):1415-6. PubMed ID: 11098507
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of biochemical recurrence of prostate cancer with granulocyte-macrophage colony-stimulating factor secreting, allogeneic, cellular immunotherapy.
    Urba WJ; Nemunaitis J; Marshall F; Smith DC; Hege KM; Ma J; Nguyen M; Small EJ
    J Urol; 2008 Nov; 180(5):2011-7; discussion 2017-8. PubMed ID: 18801509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On immunotherapies and cancer vaccination protocols: a mathematical modelling approach.
    Joshi B; Wang X; Banerjee S; Tian H; Matzavinos A; Chaplain MA
    J Theor Biol; 2009 Aug; 259(4):820-7. PubMed ID: 19446568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cell-based immunotherapy targeting Wilms' tumor 1 in patients with recurrent malignant glioma.
    Sakai K; Shimodaira S; Maejima S; Udagawa N; Sano K; Higuchi Y; Koya T; Ochiai T; Koide M; Uehara S; Nakamura M; Sugiyama H; Yonemitsu Y; Okamoto M; Hongo K
    J Neurosurg; 2015 Oct; 123(4):989-97. PubMed ID: 26252465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial.
    Vermorken JB; Claessen AM; van Tinteren H; Gall HE; Ezinga R; Meijer S; Scheper RJ; Meijer CJ; Bloemena E; Ransom JH; Hanna MG; Pinedo HM
    Lancet; 1999 Jan; 353(9150):345-50. PubMed ID: 9950438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant therapy in gastric cancer: can we prevent recurrences?
    Meyerhardt JA; Fuchs CS
    Oncology (Williston Park); 2003 May; 17(5):714-21, 728; discussion 728-9, 732-3. PubMed ID: 12800796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results obtained by intravesical instillation of BCG in superficial bladder tumors].
    Romics I; Dietmar B; Christoph R
    Orv Hetil; 1990 Jan; 131(1):25-8. PubMed ID: 2405331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The immunotherapy of bladder tumors and the immunoprophylaxis of disease recurrence].
    Korovin AI; Savvin VT
    Urol Nefrol (Mosk); 1996; (1):19-21. PubMed ID: 8659034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of recurrent ovarian cancer successfully treated with adoptive immunotherapy and lentinan.
    Fujimoto K; Tomonaga M; Goto S
    Anticancer Res; 2006; 26(6A):4015-8. PubMed ID: 17195451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.